Speakers - BIO Digital

Stephen M. Hahn, MD

COMMISSIONER OF FOOD AND DRUGS, U.S. FOOD AND DRUG ADMINISTRATION

Fireside Chat with FDA Commissioner Dr. Stephen M. Hahn

Federico Mingozzi, PhD

CHIEF SCIENTIFIC OFFICER, SPARK THERAPEUTICS

The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond

United States

James Sabry, MD, PhD

GLOBAL HEAD, PHARMA PARTNERING, ROCHE

The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond

Raolat Abdulai, MD, MS

CLINICAL DIRECTOR OF RESEARCH, SANOFI

Digital Health in Respiratory Care – The Next Frontier

Cambridge, Massachusetts, United States

Amy Abernethy, MD, PhD

PRINCIPAL DEPUTY COMMISSIONER AND ACTING CHIEF INFORMATION OFFICER, FOOD AND DRUG ADMINISTRATION

The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable

Washington DC, United States

Charlotte Abitbol

BUSINESS DEVELOPMENT DIRECTOR HEALTHCARE, BUSINESS FRANCE

France, the most attractive country in Europe for FDI

San Francisco, California, United States

Wade Ackerman, JD

PARTNER, COVINGTON & BURLING

Patient-Centric 2.0: Are We Ready for Decentralized Trials?

Los Angeles, California, United States

Julian Adams, PhD

CEO, GAMIDA CELL

Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer

Boston, Massachusetts, United States

Amos Adler

CEO, A4I

A4i

Toronto, Ontario, Canada

Sudhir Agarwal, FRSC, D. Phil

VISITING PROFESSOR IN THE DEPARTMENT OF MEDICINE, UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL; FOUNDER AND PRESIDENT, ARNAY SCIENCES, ARNAY SCIENCES

'N of Few' - Clinical Trial Design for Small Cohorts

United States

Priyanka Agarwal, MBA, MD

DIRECTOR, DIGITAL HEALTH, MYOKARDIA, INC.

Addressing the Unmet Need in Cardiovascular Disease Development

Amirah Al Idrus

EDITOR, FIERCEBIOTECH

Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives

United States

Meg Alexander

HEAD, REPUTATION & RISK MANAGEMENT PRACTICE, SYNEOS HEALTH COMMUNICATIONS

In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?

New York, New York, United States

Paul Aliu, MBA, MRPharmS, PharmD

GLOBAL HEAD MEDICAL GOVERNANCE, CHIEF MEDICAL OFFICE, NOVARTIS PHARMA AG

Bioethics Through the Lens of a Pandemic

Basel, Switzerland

Rob Allen

SENIOR VICE PRESIDENT AND CHIEF OPERATING OFFICER, INTERMOUNTAIN HEALTHCARE SYSTEMS

Reinventing Partnerships to Deliver Value for Patients & Society

Salt Lake City, Utah, United States

Michael Altorfer

CEO, SWISS BIOTECH ASSOCIATION

Biotech Hub Switzerland - stronger and more diverse

Brad Amendt

OWNER AND CSO, NATUREMIRI, LLC

NaturemiRI, LLC

Iowa City, Iowa, United States

Margaret Anderson

MANAGING DIRECTOR, DELOITTE CONSULTING LLP

Fireside Chat with Dave Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company

Washington, United States

Ayla Annac

CEO/PRESIDENT, INVIVOSCIENCES, INC.

InvivoSciences, inc.

Madison, Wisconsin, United States

Ami Appelbaum

CHAIRMAN OF THE BOARD, ISRAEL INNOVATION AUTHORITY & CHIEF SCIENTIST, MINISTRY OF ECONOMY AND INDUSTRY

International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?

TEL AVIV-YAFO, Israel

Fumito Aranami

MANAGER, OITA IAM

Oita IAM

Oita , Japan

Ksenija Pavletic Aranicki, MBA, MSc

CEO, GEDEON RICHTER PREGLEM

Redefining BioPharma in a Female-Forward World

Geneva, Switzerland

Arsalan Arif

CEO AND FOUNDER, ENDPOINTS NEWS

Gene Therapy: The Long Horizon and Broad Challenges

Lawrence, Kansas, United States

Cameron Arterton

VICE PRESIDENT, TAX POLICY, EMERGING COMPANIES, BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)

Federal Economic Recovery Efforts for Small Biotechnology Companies

Examining Foreign-Source Threats to Biotechnology: A Conversation with the National Security Community

Washington, United States

Phyllis Arthur, MBA

VICE PRESIDENT, INFECTIOUS DISEASES AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION

Leveraging Innovative Technology to Treat COVID-19 Patients

A Way Forward: Winning the War on COVID through Vaccines

The Need for Speed: Developing COVID-19 Vaccines and Therapeutics

Washington, District Of Columbia, United States

Hartley Atkinson

CEO AND FOUNDER, AFT PHARMACEUTICALS

AFT Pharmaceuticals

Auckland, New Zealand

Joel Austin, Please Select, PhD

CSO, CHIROMICS LLC

Chiromics LLC

West Windsor, New Jersey, United States

Mario Avarello, BSc, MSc, PhD

SCIENTIFIC ACCOUNT MANAGER BUSINESS DEVELOPMENT, GENOMIC VISION

Genomic Vision

Bagneux, France

Wooyeol Baek

CEO, PLCOSKIN INC.

PLCOSKIN Inc.

Seoul, Korea, Republic of

Christopher Bahl, MS, PhD

HEAD OF PROTEIN DESIGN, INSTITUTE FOR PROTEIN INNOVATION

Institute for Protein Innovation

Boston, Massachusetts, United States

Rebecca Baker, PhD

DIRECTOR, HELPING TO END ADDICTION LONG-TERM (HEAL) INITIATIVE, NATIONAL INSTITUTES OF HEALTH

Disruptive Thinking: What's Next for Pain

United States

David Baker

CEO, VALLON PHARMACEUTICALS

Vallon Pharmaceuticals

Philadelphia, Pennsylvania, United States

Cheryl Baker, PhD

SCIENTIFIC FOUNDER AND CHIEF SCIENTIFIC RESEARCH OFFICER, BIOCURITY PHARMACEUTICALS INC.

BioCurity Pharmaceuticals Inc.

Jupiter, Florida, United States

Sasha Bakhru, PhD

PRESIDENT & CHIEF EXECUTIVE OFFICER, PEROSPHERE TECHNOLOGIES

Addressing the Unmet Need in Cardiovascular Disease Development

United States

Stéphane Bancel

CHIEF EXECUTIVE OFFICER, MODERNA THERAPEUTICS, INC

A Way Forward: Winning the War on COVID through Vaccines

Cambridge, Massachusetts, United States

Jianxin Bao

CEO, GATEWAY BIOTECHNOLOGY, INC.

Gateway Biotechnology Inc.

Kent, Ohio, United States

Erica Barnes

EXECUTIVE DIRECTOR, MINNESOTA RARE DISEASE ADVISORY COUNCIL

Gene Therapy: The Long Horizon and Broad Challenges

Saint Paul, Minnesota, United States

Jenny Barnett

CEO, MONUMENT TX

Digital Biomarkers: A New Dawn in CNS R&D

Cambridge, United Kingdom

Dror Bashan

CEO, PROTALIX BIOTHERAPEUTICS

Protalix BioTherapeutics

Carmiel, Israel

Ken Batchelor, PhD

CEO, NOVATARG THERAPEUTICS

NovaTarg Therapeutics

Research Triangle Park, North Carolina, United States

Alison Bateman-House, MPH, PhD, MA

ASSISTANT PROFESSOR, DIVISION OF MEDICAL ETHICS, NYU GROSSMAN SCHOOL OF MEDICINE

Bioethics Through the Lens of a Pandemic

New York, New York, United States

Steve Bates

CHIEF EXECUTIVE OFFICER, UK BIOINDUSTRY ASSOCIATION (BIA)

International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?

London, United Kingdom

Jake Bauer

CHIEF BUSINESS OFFICER, MYOKARDIA

Precision Medicine Outside Oncology: One Size Does Not Fit All

San Francisco, California, United States

Bruce Bauer, PhD

CEO, TAE LIFE SCIENCES

TAE Life Sciences

Foothill Ranch, California, United States

Shannon Baumann

SENIOR DIRECTOR, ACCESS VALUE AND EVIDENCE STRATEGY, BLUEBIRD BIO

Precision financing for Durable/curative Therapies

Susan Baxter, PhD

EXECUTIVE DIRECTOR, CALIFORNIA STATE UNIVERSITY PROGRAM FOR EDUCATION AND RESEARCH IN BIOTECHNOLOGY

Diversity and Inclusion in the Bio-innovation Ecosystem

San Diego, California, United States

Mandy Bazile

DIRECTOR, GOVERNMENT AFFAIRS, PUBLIC POLICY & REIMBURSEMENT, GENENTECH

Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies

Yvan Beaudoin

CEO, THORASYS

Thorasys

Montreal, Quebec, Canada

Dirk Beelen

DIRECTOR , HEALTH AND MEDICAL INDUSTRIES SOUTH AUSTRALIA

Health and Medical Industries South Australia

Adelaide, Australia

Sue Behrens, PhD

RATHMANN PROFESSOR IN BIOPROCESSING AND DIRECTOR OF THE AMGEN BIOPROCESSING CENTER, KECK GRADUATE INSTITUTE

Discover/Develop: But How Will you Manufacture Your Therapeutic?

Claremont, California, United States

Piraye Beim

CEO, CELMATIX

Celmatix

New York, New York, United States

Ksenia Belkina

CEO, CARDIOMO CARE, INC.

Cardiomo Care, Inc.

New York, New York, United States

Marc L. Belsky

CHIEF FINANCIAL OFFICER AND SECRETARY, KEZAR LIFE SCIENCES

Federal Economic Recovery Efforts for Small Biotechnology Companies

South San Francisco, California, United States

Rahima Benhabbour

FOUNDER & DIRECTOR, ANELLEO, INC.

Anelleo, Inc.

Chapel Hill, North Carolina, United States

Richard Berenson

CHIEF EXECUTIVE OFFICER, THERMALIN INC.

Thermalin Inc.

Waban, Massachusetts, United States

Fabian Berkemeier

DIRECTOR, VALUE AND ACCESS STRATEGY, IGES INSTITUT GMBH

How will healthcare systems adapt to the Post-COVID-19 World?

Berlin, Germany

Seth Berkley

CEO, GAVI, THE VACCINE ALLIANCE

A Way Forward: Winning the War on COVID through Vaccines

New York, New York, United States

Jeff Berkowitz, JD

CEO AND DIRECTOR, REAL ENDPOINTS

Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases

New Jersey, United States

Sylvain Berlemont

CEO, KEEN EYE

KEEN EYE

Paris, France

Arnaud Bernaert

HEAD OF HEALTH AND HEALTHCARE, MEMBER OF THE EXECUTIVE COMMITTEE, WORLD ECONOMIC FORUM

Reinventing Partnerships to Deliver Value for Patients & Society

cologny, Switzerland

Brian Berridge, PhD

ASSOCIATE DIRECTOR, NATIONAL TOXICOLOGY PROGRAM; SCIENTIFIC DIRECTOR, DIVISION OF NTP, NIH

Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development

United States

Gordon Bethwaite

ACTING CEO, NOVAI

Novai

San Diego, California, United States

Ami Bhatt

ASSISTANT PROFESSOR, MEDICINE-HEMATOLOGY AND GENETICS, STANFORD UNIVERSITY

Next Generation Advances in Human Microbiome Research

Stanford, California, United States

Indu Bhushan

CEO AYUSHMAN BHARAT & NATIONAL HEALTH AUTHORITY, GOVERNMENT OF INDIA

The Lure of Universal Healthcare ! What India is doing in Healthcare

New Delhi, India

Barbara Bierer, MD

FACULTY DIRECTOR, MULTI-REGIONAL CLINICAL TRIALS CENTER OF BRIGHAM AND WOMEN'S HOSPITAL AND HARVARD

Including the Patient Voice to Advance Diversity and Support Clear Communications

Cambridge, Massachusetts, United States

Igor Bilinsky

CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS

Oncternal Therapeutics

San Diego, California, United States

Louise Binder

HEALTH POLICY CONSULTANT, SAVE YOUR SKIN FOUNDATION

Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals

Paul Biondi

EXECUTIVE PARTNER, FLAGSHIP PIONEERING

Getting a seat at the table: how can new small companies enter the oncology space?

Princeton, New Jersey, United States

Lars Birgerson, MD, PhD

PRESIDENT & CEO, ADLAI NORTYE USA INC.

Adlai Nortye USA Inc

North Brunswick, New Jersey, United States

Teresa Bitetti

PRESIDENT, GLOBAL ONCOLOGY, TAKEDA

What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting

Fritz Bittenbender

SENIOR VICE PRESIDENT, GOVERNMENT AFFAIRS, GENENTECH, A MEMBER OF THE ROCHE GROUP

In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?

Washington, United States

Clare Blain

CEO, LIFE SCIENCES QUEENSLAND LIMITED

Queensland, Australia - Global Innovation Hub

Brisbane, Australia

Leah Bloom, PhD

SENIOR VICE PRESIDENT, EXTERNAL INNOVATION AND STRATEGIC ALLIANCES, AVEXIS, A NOVARTIS COMPANY

AveXis, Inc., a Novartis Company

Bannockburn, Illinois, United States

Vincent Blouin, BSc, MBA

CHIEF MARKETING OFFICER, RASPBERRY SCIENTIFIC INC.

Raspberry Scientific Inc.

Magog, Quebec, Canada

Ken Blount, PhD

CHIEF SCIENTIFIC OFFICER, REBIOTIX

Keys to the Cure: Will the Microbiome Live Up to the Hype?

United States

Jeffrey Blue

DIRECTOR OF VACCINE DRUG PRODUCT DEVELOPMENT AND NEW TECHNOLOGIES, MERCK & CO.

Beyond the Needle: Novel Approaches to Vaccine Delivery

Jeffrey Bockman, PhD

EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)

Future of IO Checkpoint Combinations

United States

Sierra Bodor, BS

PUBLIC HEALTH PROGRAM MANAGER, HEPATITIS B FOUNDATION

Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market

Doylestown, Pennsylvania, United States

Natasha Bonhomme

CHIEF STRATEGY OFFICER, GENETIC ALLIANCE

Next Generation Orphan Drug Incentives

Washington, United States

Aarash Bordbar, PhD

CO-FOUNDER & CTO, SINOPIA BIOSCIENCES, INC.

Sinopia Biosciences, Inc.

San Diego, California, United States

Christophe Bourdon

VICE PRESIDENT AND GENERAL MANGER, ONCOLOGY (US OPERATIONS), AMGEN INC.

International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?

Vienna, Austria

Terry Bowlin

PRESIDENT & CEO, MICROBIOTIX, INC.

Microbiotix, Inc.

Worcester, Massachusetts, United States

Matt Bradley, PhD

CHAIRMAN, PRESIDENT, FOUNDER, SAJE PHARMA, LLC

SAJE Pharma, LLC

Kalispell, Montana, United States

Kerrie Brady, Bpharm, MBA, MSc

CO-FOUNDER AND FORMER CBO CENTREXION

Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences

United States

Kimberly Brandt

PRINCIPAL DEPUTY ADMINISTRATOR FOR POLICY & OPERATIONS, CENTERS FOR MEDICAID & MEDICARE SERVICES

Disruptive Thinking: What's Next for Pain

Baltimore, Maryland, United States

Joel Braunstein, MBA, MD

CEO, C2N DIAGNOSTICS, LLC

Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate

St. Louis, Missouri, United States

Graham Brearley

GENERAL MANAGER, MADISON, CATALENT BIOLOGICS

How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships

Isaac Bright

CEO, RUBRYC THERAPEUTICS, INC.

RubrYc Therapeutics, Inc.

San Carlos, California, United States

Alex Brill

RESIDENT FELLOW, AMERICAN ENTERPRISE INSTITUTE

How can the U.S. cultivate a strong and competitive biosimilars market?

Washington, District Of Columbia, United States

Remy Brim, PhD

VICE PRESIDENT REGULATORY POLICY AND STRATEGY, BGR GOVERNMENT AFFAIRS

In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?

Washington, District Of Columbia, United States

Nicholas Brooke

EXECUTIVE DIRECTOR, PATIENT FOCUSED MEDICINES DEVELOPMENT

Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?

Brussels,

Nick Brown

NORTH AMERICAN BUSINESS DEVELOPMENT MANAGER, RETROGENIX LIMITED

Retrogenix Limited

Chinley, High Peak, United Kingdom

Shane Brown

DIRECTOR BUSINESS DEVELOPMENT – WESTERN NORTH AMERICA , OLON RICERCA BIOSCIENCE LLC

Olon S.p.A

Concord, Ohio, United States

Ronan Brown

SENIOR VP & HEAD, INTEGRATED GLOBAL COMPLIANCE, IQVIA, IQVIA

IQVIA

San Diego, California, United States

Jason Brown, PhD

CHIEF BUSINESS OFFICER, EVEREST MEDICINES

Licensing Clinical-Stage Assets to Greater China

San Diego, California, United States

Wilson Bryan, MD

DIRECTOR, OFFICE OF TISSUES AND ADVANCED THERAPIES, FDA

Race Against the Clock: Bringing New Cell and Gene Therapies to Market

White Oak, Maryland, United States

Matt Bryant, PharmD

VP, GLOBAL MEDICAL AFFAIRS, EIGER BIOPHARMACEUTICALS

Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market

Palo Alto, California, United States

John Bucksath

CHIEF EXECUTIVE OFFICER AND BOARD MEMBER, KCAS, LLC

Bioscience Professional Toolkit - How to successfully transition to a post-academic career

Shawnee Mission, Kansas, United States

Sanjay Budhdeo, MD

BUSINESS DEV. DIRECTOR, OWKIN

Can AI Prevent Epidemics?

Hugues Bultot

CEO, EXOTHERA

Exothera

Brussels, Belgium

TIMOTHY BURLAND, BSc, PhD

DIRECTOR OF BUSINESS DEVELOPMENT, SCARAB GENOMICS LLC

Scarab Genomics

Wisconsin, United States

Stephen Byers

PROFESSOR OF ONCOLOGY, DIRECTOR, GUMC SHARED RESOURCES , DIVINER THERAPEUTICS LLC

Diviner Therapeutics LLC

Washington, District Of Columbia, United States

Jeff Bylund, PhD

APPLICATIONS MANAGER, NIKON INSTRUMENTS

Nikon BioImaging Lab

Melville, New York, United States

Cluster C.H.I.CO.

CLUSTER C.H.I.CO., CLUSTER C.H.I.CO.

Cluster C.H.I.CO.

Rome, Italy

Andrew Cap, MD, PhD

DIRECTOR OF RESEARCH, US ARMY INSTITUTE OF SURGICAL RESEARCH/HEMATOLOGY-ONCOLOGY CONSULTANT TO THE US ARMY SURGEON GENERAL/ PROFESSOR OF MEDICINE, UNIFORMED SERVICES UNIVERSITY, US ARMY INSTITUTE OF SURGICAL RESEARCH

The human biologic response to vascular injury: a complex interaction among inflammation (innate and adaptive), coagulation and acuity of the injurious stimulus

Arthur L. Caplan, PhD

PROFESSOR AND HEAD, DIVISION OF MEDICAL ETHICS, NYU SCHOOL OF MEDICINE

Bioethics Through the Lens of a Pandemic

New York, New York, United States

EJane Caraway

DIRECTOR OF LIFE SCIENCES, GEORGIA DEPARTMENT OF ECONOMIC DEVELOPMENT

From Innovation to Impact...Georgia USA

Atlanta, Georgia, United States

Anne-Marie Carbonell, MD

CEO, ONCOSYNERGY, INC

OncoSynergy, Inc

Greenwich, Connecticut, United States

Justin Carbungco

ASSOCIATE DIRECTOR, SMALL SCALE MANUFACTURING, SAMSUNG BIOLOGICS

Economics of Stainless Steel and Single-Use Systems

Marlene Cardin

DIRECTOR OF PROJECTS, PROSENSUS

ProSensus

Burlington, Ontario, Canada

Martha Carlin

CEO/FOUNDER, THE BIOCOLLECTIVE, LLC

The BioCollective, LLC

Denver, Colorado, United States

Steve Carney

MANAGING EDITOR, DRUG DISCOVERY TODAY

Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery

Digital Biomarkers: A New Dawn in CNS R&D

Richmond, United Kingdom

John Carpten, PhD

PROFESSOR, CHAIR, AND DIRECTOR, UNIVERSITY OF SOUTHERN CALIFORNIA

Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities

Los Angeles, California, United States

Alan Carr

SENIOR ANALYST, NEEDHAM & CO.

How to Fix the Broken Antibiotics Market: A Rare Disease Case Study

New York, New York, United States

Dorn Carranza, MBA, PhD

DIRECTOR OF INNOVATION AND INDUSTRY PARTNERSHIPS, VENTUREWELL

Diversity and Inclusion in the Bio-innovation Ecosystem

Hadley, Massachusetts, United States

Rich Carter

VICE PRESIDENT, CHIEF DIGITAL OFFICER, ELI LILLY AND COMPANY

The Emerging Role of Digital Biomarkers in Cognitive Impairment

Indianapolis, Indiana,

Charlotte Casebourne

CEO, THEOLYTICS

Theolytics

Oxford, United Kingdom

Alan Cash

CEO, METVITAL, INC.

MetVital, Inc.

San Diego, California, United States

Grace Castillo-Soyao

FOUNDER/CHIEF INNOVATION & STRATEGY OFFICER , SELF CARE CATALYSTS

Self Care Catalysts Inc

Toronto , Ontario, Canada

Susan Catalano, PhD

CO-FOUNDER AND CSO, COGNITION THERAPEUTICS

Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate

Pittsburgh, Pennsylvania, United States

Laura Cerni

CLUSTER MANAGER, CBM - SMART HEALTH CLUSTER OF FRIULI VENEZIA GIULIA REGION

CBM - Cluster Smart Health of Friuli Venezia Giulia, Italy

Trieste, Italy

Jacob Chacko, MD

PRESIDENT, CHIEF EXECUTIVE OFFICER AND BOARD MEMBER, ORIC PHARMACEUTICALS

Looking for the Next Targeted Oncology Blockbuster

South San Francisco, California, United States

Chang Hoon Chae

GENERAL MANAGER, CELLDI

CELLDI

Jeollabuck Do, Korea, Republic of

Sharon Chan, MBA, MPH, D. Phil

HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION

How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond

China

Robert Charles, JD, LLM, MPH

CHIEF, MEDICAL RESEARCH LAW, US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND

How to Leverage Military Non-Dilutive Funding for Your Product Development Plan

Fort Detrick, Maryland, United States

Helen Chen

GREATER CHINA MANAGING PARTNER, L.E.K. CONSULTING, LLC

How will healthcare systems adapt to the Post-COVID-19 World?

Shanghai, China

Anthony (Tony) Chen

PARTNER, JONES DAY

WHY PATENTS STILL MATTER: Building Your Patent Portfolio for Global Collaborations

Shanghai, China

Mo Chen

CEO, WNT SCIENTIFIC

Wnt Scientific LLC

New York, New York, United States

Ruoxi Chen

ASSOCIATE, WARBURG PINCUS

Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty

New York, New York, United States

Andrea Chicca

CEO, CO-FOUNDER, SYNENDOS THERAPEUTICS

Synendos Therapeutics

Allschwil, Switzerland

Constantine Chinoporos

CHIEF BUSINESS OFFICER, BOSTON PHARMACEUTICALS

Boston Pharmaceuticals

Cambridge, Massachusetts, United States

Lorraine Chiroiu

CHIEF EXECUTIVE OFFICER, AUSBIOTECH

Australia - Global Innovation Hub

Melbourne, Australia

Ho Cho, PhD

SVP, DISCOVERY BIOTHERAPEUTICS, BRISTOL MYERS SQUIBB

Bispecific Antibodies Catching Fire

San Diego, California, United States

Mario Chojkier

CO-FOUNDER AND CHIEF MEDICAL OFFICER, XFIBRA, INC.

XFIBRA, Inc.

Del Mar, California, United States

Michael Chui, MS, PhD

PARTNER, MCKINSEY & COMPANY

The Bio Revolution: Innovations transforming economies, societies, and our lives

San Francisco, California, United States

Jon Jongsik Chun, PhD

CEO, CHUNLAB, INC.

ChunLab, Inc.

Seoul, Korea, Republic of

Guy Cipriani, BS, MBA

CBO, MICROBION CORPORATION

Microbion Corporation

Bellingham, Washington, United States

Ryan Cirz

CHIEF SCIENTIFIC OFFICER, ACTING CHIEF EXECUTIVE OFFICER, REVAGENIX, INC.

How to Fix the Broken Antibiotics Market: A Rare Disease Case Study

South San Francisco, California, United States

Paul Cizdziel, MBA, PhD

GLOBAL MARKET DEVELOPMENT, YOKOGAWA ELECTRIC CORPORATION

Yokogawa Electric Corporation

Yokohama, Japan

Laura Clague

CHIEF FINANCIAL OFFICER, RETROPHIN

Next Generation Orphan Drug Incentives

San Diego, California, United States

Christopher Clegg

PRESIDENT, TRIA BIOSCIENCE

TRIA Bioscience

Seattle, Washington, United States

Jeffrey Cleland

CHAIRMAN, CEO & PRESIDENT, ASHVATTHA THERAPEUTICS

Ashvattha Therapeutics

Redwood City, California, United States

Dan Close, PhD

CHIEF SCIENTIFIC OFFICER, 490 BIOTECH

490 BioTech

Knoxville, Tennessee, United States

Jennifer Cochran, PhD

PROFESSOR AND CHAIR, BIOENGINEERING, STANFORD UNIVERSITY

Bispecific Antibodies Catching Fire

California, United States

Oren Cohen, MD

HEAD OF CPS AND CHIEF MEDICAL OFFICER, COVANCE

Covance

Ezra Cohen, MD

MEDICAL ONCOLOGIST, ASSOCIATE DIRECTOR, TRANSLATIONAL SCIENCE, MOORES CANCER CENTER, UC SAN DIEGO HEALTH

What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting

La Jolla, California, United States

Ellen Coleman

PRESIDENT & CEO, VOZ ADVISORS

Patient Engagement in Gene and Cell Therapy: What is Different?

New York, New York, United States

Tony Coles, MD

CHIEF EXECUTIVE OFFICER AND CHAIRPERSON OF THE BOARD OF DIRECTORS, CEREVEL THERAPEUTICS, LLC

Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World

Boston, Massachusetts, United States

Grace Colon

PRESIDENT & CEO, INCARDA THERAPEUTICS INC.

Digital Health in Respiratory Care – The Next Frontier

United States

Ian Colrain

PRESIDENT - BIOSCIENCES DIVISION, SRI INTERNATIONAL

SRI International

Menlo Park , California, United States

Andrea Conforto

SALES & MARKETING – BIOSERVICES DIRECTOR , OLON S.P.A

Olon S.p.A.

Milano, Italy

Clive Cookson

SCIENCE EDITOR, FINANCIAL TIMES

Science on the Front Lines & on the Front Page

London, United Kingdom

Pierre Courteille, MBA

CHIEF COMMERCIAL OFFICER & VICE PRESIDENT OF BUSINESS DEVELOPMENT, ABIVAX; VICE PRESIDENT, FRANCE BIOTECH, ABIVAX; FRANCE BIOTECH

Start Me Up: How Can Europe’s Biotech Sector Combat the Coronavirus?

PARIS, France

Scott Cousins, MD

PROFESSOR OF OPHTHALMOLOGY AND IMMUNOLOGY, DUKE EYE CENTER

Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation

Durham, North Carolina, United States

Gabriela Couto

PRESIDENT, CR BIOMED

CR biomed

San José, Costa Rica

Stan Crooke, MD, PhD

FOUNDER, CEO AND CHAIRMAN OF THE BOARD, N-LOREM FOUNDATION

n-Lorem Foundation

Carlsbad, California, United States

Everett Crosland

SVP, COMMERCIAL, APPLIEDVR

Payers and Digital Therapeutics: How to Get Coverage When Doctors Prescribe Software

United States

Roger Crystal

PRESIDENT AND CEO, OPIANT PHARMACEUTICALS

Opiant Pharmaceuticals

Santa Monica, California, United States

Michael Curran

ASSOCIATE PROFESSOR, DEPARTMENT OF IMMUNOLOGY , MD ANDERSON CANCER CENTER

Future of IO Checkpoint Combinations

Houston, Texas, United States

Wendy Cutler

VICE PRESIDENT AND MANAGING DIRECTOR, WASHINGTON, D.C. OFFICE, ASIA SOCIETY POLICY INSTITUTE

International Trade in the Times of COVID-19

Corey Cutler, FRCP (C), MD, MPH

PHYSICIAN, DIRECTOR AND MEDICAL DIRECTOR OF THE ADULT STEM CELL TRANSPLANTATION AND STEM CELL TRANSPLANTATION SURVIVORSHIP PROGRAMS, DANA FARBER CANCER INSTITUTE

Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer

Bassil Dahiyat

PRESIDENT AND CHIEF EXECUTIVE OFFICER, XENCOR

Bispecific Antibodies Catching Fire

Monrovia , California, United States

Dave Daly

CHIEF EXECUTIVE OFFICER, THRIVE EARLIER DETECTION CORP.

How Can the Liquid Biopsy Market Realize Its $30B Potential?

Cambridge, Massachusetts, United States

Corinne Danan

EVP, PARTNERSHIPS BU, HALIODX

HalioDx

Marseille, France

Doug Danison, MBA

SVP, HEAD OF ACCESS VALUE & EVIDENCE STRATEGY, BLUEBIRD BIO

Financing Transformative Therapies: Cross-sector perspective on value, payment and real-world evidence

Cambridge, Massachusetts, United States

Mark Dant

FOUNDER AND EXECUTIVE DIRECTOR, THE RYAN FOUNDATION; BOARD CHAIR, EVERYLIFE FOUNDATION FOR RARE DISEASES

Genomic medicine and bioethics – Ushering in a new era of responsible healthcare

Dallas, Texas, United States

Barry Datlof

CHIEF, BUSINESS DEVELOPMENT AND COMMERCIALIZATION, U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND

Many Happy Returns: Federal Labs as Commercialization Partners

Fort Detrick, MD, Maryland, United States

Nathaniel David, PhD

CO-FOUNDER AND PRESIDENT, UNITY BIOTECHNOLOGY

Redefining What it Means to Get Old: New Breakthroughs in Aging Biology

Hugh Davis, PhD

CHIEF OPERATING OFFICER & PRESIDENT, BIOSION USA, INC., BIOSION, INC.

Biosion, Inc.

Newark, Delaware, United States

Khrystal K Davis, JD

PATIENT ADVOCATE, TEXAS RARE ALLIANCE

Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage

Austin, Texas, United States

Jared Davis

VICE PRESIDENT OF TECHNICAL OPERATIONS AND MANUFACTURING, ARCTURUS THERAPEUTICS

How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships

United States

Philip Davy, PhD

DIRECTOR OF BUSINESS DEVELOPMENT, BRAIZON THERAPEUTICS, INC.

Braizon Therapeutics, Inc.

Tokyo, Japan

Marianne De Backer, MBA, PhD

GLOBAL HEAD OF BUSINESS DEVELOPMENT & LICENSING, EXECUTIVE COMMITTEE MEMBER, BAYER PHARMACEUTICALS

Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build

Berkley, California, United States

Isabelle de Cremoux

CEO AND MANAGING PARTNER, SEVENTURE

Keys to the Cure: Will the Microbiome Live Up to the Hype?

Mark de Groot

CEO, PATTERN PHARMA INC.

Pattern Pharma Inc.

Toronto, Ontario, Canada

Patrik De Haes, MD

CEO, OXURION NV

OXURION NV

LEUVEN, Belgium

Alban de La Sablière

SANOFI PARTNERING HEAD, SANOFI

Sanofi

Paris, France

Robert DeBerardine

CHIEF INTELLECTUAL PROPERTY COUNSEL, JOHNSON & JOHNSON

Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future

Bridgewater, New Jersey, United States

Anthony DeBoer

DIRECTOR, BUSINESS DEVELOPMENT, SYNAFFIX BV

Synaffix BV

Amsterdam, Netherlands

Marc Dechamps

DIRECTOR INTERNATIONAL AFFAIRS , BIOWIN

Belgium beyond biotech

Gosselies, Belgium

Mark Dertzbaugh, PhD

ACTING PRINCIPAL ASSISTANT FOR RESEARCH & TECHNOLOGY , U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND

How to Leverage Military Non-Dilutive Funding for Your Product Development Plan

Fort Detrick, Maryland, United States

Raymond Deshaies

SENIOR VICE PRESIDENT, GLOBAL RESEARCH, AMGEN INC.

The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable

United States

Sriram Devanathan, BSc, MSc, PhD

SCIENTIFIC DIRECTOR, MITOCHONDRIA IN MOTION

Mitochondria in Motion, Inc

Saint Louis, Missouri, United States

Ratna Devi

CHAIR, INTERNATIONAL ALLIANCE OF PATIENT ORGANIZATIONS

Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?

Simon Dew

VP BUSINESS DEVELOPMENT , EVOX THERAPEUTICS LTD

Evox Therapeutics Ltd

Oxford, United Kingdom

Nazneen Dewji

CEO, CENNA BIOSCIENCES INC.

Cenna Biosciences Inc.

La Jolla, California, United States

Willem Dhooge

GENERAL MANAGER , FLANDERS.BIO

Belgium beyond biotech

Philippe Diaz

CEO, DERMAXON LLC

DermaXon

Missoula, Montana, United States

MG Dinesh

CHIEF SCIENTIST, AGASTIYA BIOTECH

Agastiya Biotech

Temecula, California, United States

Gregory DiRusso, MD

VICE PRESIDENT, MEDICINE TEAM LEAD, HEMOPHILIA, PFIZER

Advancing Rare Disease Diagnosis and Drug Development Through Partnership

Greg Divis

CEO, AVADEL PHARMACEUTICALS

Avadel Pharmaceuticals

Chesterfield, MO, Missouri, United States

J. Kevin Donahue, MD

CO-FOUNDER, DIRECTOR, RITHIM BIOLOGICS®, INC.

Rithim Biologics®, Inc.

Hopkinton, Massachusetts, United States

Patricia Donahue

CEO, PAD BIOPHARMA

GETTING TO YES: Negotiating IP Terms in Contracts

Sonoma, Arizona, United States

Oreola Donini, PhD

CHIEF SCIENTIFIC OFFICER, SOLIGENIX, INC.

Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance

Princeton, New Jersey, United States

Douglas Drake

DIRECTOR CUSTOMER SOLUTIONS, CLINERION LTD

Clinerion Ltd

Basel, Switzerland

Kelly Drew

CHIEF EXECUTIVE OFFICER, BE COOL PHARMACEUTICS

Be Cool Pharmaceutics

Fairbanks, Alaska, United States

Caroline M. Duffy, PhD

BIOPROCESS SCIENTIST, CYTIVA

Bioscience Professional Toolkit - How to successfully transition to a post-academic career

United States

Denis DUFRANE

CEO, NOVADIP BIOSCIENCES

NOVADIP Biosciences

MONT-SAINT-GUIBERT, Belgium

Rajeev Dutt

PRESIDENT, CEO, CO-FOUNDER, AI DYNAMICS

How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond

Shahram Ebadollahi

GLOBAL HEAD OF DATA SCIENCE AND AI, NOVARTIS

The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable

White Plains, New York, United States

Stephen Eck

CHIEF MEDICAL OFFICER, IMMATICS BIOTECHNOLOGIES

How Can the Liquid Biopsy Market Realize Its $30B Potential?

Ryan Eckmeier

JOINT PROJECT MANAGER FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL, CCDC CHEMICAL BIOLOGICAL CENTER

Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics

Fort Detrick, Maryland, United States

Ben Edwards

CHIEF STRATEGY OFFICER, AVANCE CLINICAL

Avance Clinical

Adelaide, Australia

Mark Edwards

MANAGING DIRECTOR, BIOSCIENCE ADVISORS

Restarting the Bioeconomy: What IPO and Alliance Data tell us

Walnut Creek, California, United States

Konstantinos Efthymiopoulos, MBA, PhD, PharmD

DESIGNATED MANAGING DIRECTOR, SYNDERMIX AG

SynDermix AG

Stans, Switzerland

Tony Eglezos

VP BUSINESS DEVELOPMENT, STARPHARMA HOLDINGS LIMITED

Starpharma Holdings Limited

Abbotsford, Australia

Joe Eiden

CHIEF CLINICAL CONSULTANT, FLUGEN INC.

The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?

Alan Eisenberg

VICE PRESIDENT, GLOBAL GOVERNMENT RELATIONS AND PUBLIC POLICY, ALNYLAM PHARMACEUTICALS, INC.

How will healthcare systems adapt to the Post-COVID-19 World?

In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?

Cambridge, Massachusetts, United States

Nathan Elia

DIRECTOR, INVESTMENT, GOVERNMENT OF VICTORIA

State Government of Victoria, Australia

Natalia Elizalde

BUSINESS DEVELOPMENT DIRECTOR, VIVEBIOTECH

VIVEbiotech

San Sebastian, Spain

Julie Eller

DIRECTOR, PATIENT CENTERED STRATEGIES |HELP & SUPPORT, ARTHRITIS FOUNDATION

Understanding the Voices of Patients: Unique Perspectives on Healthcare

Niels Emmerich

VICE PRESIDENT, GLOBAL HEAD SEARCH AND EVALUATION, ABBVIE

AbbVie

North Chicago, Illinois, United States

John Engelhardt

DIRECTOR, IMMUNO-ONCOLOGY DISCOVERY, BRISTOL MYERS SQUIBB

Future of IO Checkpoint Combinations

Steven Engle

CEO, COHBAR, INC.

Redefining What it Means to Get Old: New Breakthroughs in Aging Biology

Menlo Park, California, United States

Sandra Engle, PhD

DIRECTOR, TRANSLATIONAL CELL SCIENCES, STEM CELLS AND GENOMIC ENGINEERING, BIOGEN

Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development

United States

Steven Engle

CEO, COHBAR, INC.

CohBar, Inc.

Menlo Park, California, United States

John Erickson

CHIEF TECHNOLOGY OFFICER, NIIMBL

Discover/Develop: But How Will you Manufacture Your Therapeutic?

United States

Alexandra Erwin, PhD

DIRECTOR, TALENT DEVELOPMENT & EDUCATION, BIOKANSAS

Bioscience Professional Toolkit - How to successfully transition to a post-academic career

United States

Cartier Esham, PhD

EXECUTIVE VICE PRESIDENT, EMERGING COMPANIES, BIOTECHNOLOGY INNOVATION ORGANIZATION

Fireside Chat with FDA Commissioner Dr. Stephen M. Hahn

David Esposito

CEO, ONL THERAPEUTICS, INC.

ONL Therapeutics, Inc.

Ann Arbor, Michigan, United States

Erin Estevez

SPECIAL COUNSEL, COOLEY LLP

Federal Economic Recovery Efforts for Small Biotechnology Companies

United States

Philippe Etienne

AMBASSADOR OF FRANCE TO THE UNITED STATES

France - Pushing for global cooperation and solidarity: France’s approach to addressing this crisis

Anthony Evans

PRESIDENT, NATIONAL BLACK CHURCH INITIATIVE

National Black Church Initiative

Washington, District Of Columbia, United States

Matthias Evers

SENIOR PARTNER, MCKINSEY GLOBAL INSTITUTE

The Bio Revolution: Innovations transforming economies, societies, and our lives

Karen Fallen

HEAD OF MAMMALIAN AND MICROBIAL DEVELOPMENT AND MANUFACTURING, LONZA

Lonza Pharma & Biotech

Slough, United Kingdom

Eric Fallon

GLOBAL HEAD OF MANUFACTURING SCIENCE AND TECHNOLOGY, DRUG SUBSTANCE, GENENTECH, A MEMBER OF THE ROCHE GROUP

Discover/Develop: But How Will you Manufacture Your Therapeutic?

Erik Falvey

SR BUSINESS DEVELOPMENT DIRECTOR, IDDI

IDDI

Paris, France

Ronald Farquhar

CEO, MORNINGSIDE BIOPHARMA ADVISORY

Morningside Biopharma Advisory (MBA)

Concord, Massachusetts, United States

Anthony Fauci, MD

DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH

A Way Forward: Winning the War on COVID through Vaccines

Denise Faustman

HEAD OF IMMUNOBIOLOGY LAB, MASSACHUSETTS GENERAL HOSPITAL

Future of IO Checkpoint Combinations

Charlestown, Massachusetts, United States

Phil Febbo, MD

CMO, ILLUMINA

Fireside Chat with Dr. Phil Febbo, Chief Medical Officer, Illumina

Vic Fedeli

ONTARIO’S MINISTER OF ECONOMIC DEVELOPMENT, JOB CREATION AND TRADE, MINISTRY OF ECONOMIC DEVELOPMENT, JOB CREATION AND TRADE

Ontario, Canada: Imagination is in our DNA

Stacy Feld

HEAD, JOHNSON & JOHNSON INNOVATION, WEST NORTH AMERICA, AUSTRALIA& NEW ZEALAND, JOHNSON & JOHNSON INNOVATION CENTER

Johnson & Johnson

United States

PETER FELDMAN

CEO, ARBOR LIFE LABS

ARBOR LIFE LABS

TORONTO, Ontario, Canada

Steven Ferguson, CLP, MBA

SPECIAL ADVISOR, NIH OFFICE OF TECHNOLOGY TRANSFER

Many Happy Returns: Federal Labs as Commercialization Partners

Rockville, Maryland, United States

Stephanie Fertig

HHS SMALL BUSINESS PROGRAM LEAD, NATIONAL INSTITUTES OF HEALTH (NIH)

The Key Role of NIH in the Product Development Pipeline

United States

Justin Field

SVP OF GOVERNMENT AFFAIRS, NVCA

Federal Economic Recovery Efforts for Small Biotechnology Companies

Michael Fine

MEDICAL DIRECTOR, HEALTHNET

Activating the Value of RWD/RWE in a COVID-19 World

Huntington Beach, California, United States

Wainwright Fishburn

PARTNER, COOLEY LLP

Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty

San Diego, California, United States

Simone Fishburn, PhD

VICE PRESIDENT AND EDITOR IN CHIEF, BIOCENTURY

The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond

Fireside Chat with Mathai Mammen, MD, PhD, Global Head, Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson

Redwood City, California, United States

Michael Fitzhugh

NEWS EDITOR, BIOWORLD, CLARIVATE

'N of Few' - Clinical Trial Design for Small Cohorts

Berkeley, California, United States

Suzanne Fitzpatrick, PhD

SENIOR ADVISOR, TOXICOLOGY , THE U.S. FOOD AND DRUG ADMINISTRATION

Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development

Derwood, Maryland, United States

Kyle Flickinger

VICE PRESIDENT, BIO PHARMACEUTICAL SOLUTIONS, DEEP LENS

Deep Lens, Inc.

Chester Springs, Pennsylvania, United States

Vincent Forster

CEO, VERSANTIS

Versantis

Zurich, Switzerland

Pierre-Alexandre Fournier

CO-FOUNDER & CEO, HEXOSKIN

Can AI Prevent Epidemics?

Canada

Nicholas Franco, BSc, MBA

EVP & CHIEF BUSINESS DEVELOPMENT OFFICER, ACTELION PHARMACEUTICALS LTD, A JANSSEN PHARMACEUTICAL COMPANY OF JOHNSON & JOHNSON

Is It Time to Reconsider M&A’s Role in Portfolio Building?

Allschwil, Switzerland

John Fraser, MD, PhD

DIRECTOR, CRITICAL CARE RESEARCH GROUP, THE PRINCE CHARLES HOSPITAL AND THE UNIVERSITY OF QUEENSLAND

Can AI Prevent Epidemics?

Australia

Marlin Frechette

CORPORATE COMPLIANCE & QUALITY OFFICER, FUJIFILM IRVINE SCIENTIFIC

Race Against the Clock: Bringing New Cell and Gene Therapies to Market

California, United States

Mark Freedman, Bchir, BSc, MBA

CEO & DIRECTOR, SUNREGEN HEALTHCARE AG

SunRegen Healthcare AG

Allschwil, Switzerland

Danielle Friend, PhD

SENIOR DIRECTOR, SCIENCE AND REGULATORY AFFAIRS, BIOTECHNOLOGY INNOVATION ORGANIZATION

Race Against the Clock: Bringing New Cell and Gene Therapies to Market

Advancing Rare Disease Diagnosis and Drug Development Through Partnership

United States

Adi Frish

SENIOR VP BUSINESS DEVELOPMENT AND LICENSING, REDHILL BIOPHARMA

RedHill Biopharma

Tel Aviv, Israel

Tom Frohlich

CHIEF BUSINESS OFFICER, CHINOOK THERAPEUTICS

Precision Medicine Outside Oncology: One Size Does Not Fit All

Vancouver , British Columbia, Canada

Claus Crone Fuglsang

CHIEF SCIENCE OFFICER AND SENIOR VICE PRESIDENT OF RESEARCH AND TECHNOLOGY, NOVOZYMES

The Bio Revolution: Innovations transforming economies, societies, and our lives

Bagsvaerd, Denmark

Toshio Fujimoto, MBA, MD

GENERAL MANAGER OF SHONAN HEALTH INNOVATION PARK, TAKEDA PHARMACEUTICAL COMPANY LTD.

How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond

Fujisawa, Japan

Richard Gabriel

CEO & PRESIDENT, GLG PHARMA CORPORATION

GLG Pharma

Salem, Massachusetts, United States

Stephane Gagne

PRESIDENT & CEO, OVENSA INC.

Ovensa Inc.

Aurora, Ontario, Canada

Jeff Galvin

CEO, AMERICAN GENE TECHNOLOGIES

American Gene Technologies

Rockville, Maryland, United States

Chris Garabedian

CHAIRMAN & CEO, XONTOGENY

Derisking Early Research and Increasing Likelihood of Clinical Success

The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value

Boston, Massachusetts, United States

Steve Gardner, PhD

CEO, PRECISIONLIFE LTD

Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery

Digital Biomarkers: A New Dawn in CNS R&D

Kidlington, United Kingdom

Lou Garrison, PhD

PROFESSOR EMERITUS, THE COMPARATIVE HEALTH OUTCOMES, POLICY, AND ECONOMICS (CHOICE) INSTITUTE, DEPARTMENT OF PHARMACY, UNIVERSITY OF WASHINGTON

Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals

Mercer Island, Washington, United States

Bobby Gaspar, MD, PhD

CHIEF EXECUTIVE OFFICER, ORCHARD THERAPEUTICS

Orchard Therapeutics

Gene Therapy: The Long Horizon and Broad Challenges

London, United Kingdom

Lewis Geffen

CO-CHAIR, LIFE SCIENCES PRACTICE, MINTZ

Licensing Clinical-Stage Assets to Greater China

Boston, Massachusetts, United States

Bruce Gellin, MD, MPH

PRESIDENT, GLOBAL IMMUNIZATION, SABIN VACCINE INSTITUTE

The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?

Washington, United States

Julie Gerberding, MD, MPH

EXECUTIVE VICE PRESIDENT & CHIEF PATIENT OFFICER, MERCK & CO, INC.

Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?

The Next Frontier in HIV Innovation: The Transition to No Transmission

North Wales , Pennsylvania, United States

Chandrabali Ghose, PhD

FOUNDER AND CEO, BIOHARMONY THERAPEUTICS

Bioharmony Therapeutics

New York, New York, United States

Anirvan Ghosh, PhD

CEO, UNITY BIOTECHNOLOGY

True North: Maintaining your vision and letting scientific innovation be your guide

California, United States

Filippo Giabbani

EXECUTIVE DIRECTOR, INVEST IN TUSCANY

Invest in Tuscany

Firenze, Italy

Albert Gianchetti

PRESIDENT AND CEO, XYLOCOR THERAPEUTICS, INC.

XyloCor Therapeutics, Inc.

MALVERN, Pennsylvania, United States

Jessica Gibson

CEO AND CO-FOUNDER, ARIEL PRECISION MEDICINE, INC.

Ariel Precision Medicine, Inc.

Costa Mesa, California, United States

John Gill

PART LEADER, SAMSUNG BIOLOGICS

Get to IND Faster: Accelerated & High Performance Cell Line Development

Incheon, Korea, Republic of

Roberta Gioia

CEO, GENECHRON SRL

Genechron Srl

Rome, Italy

Prashant Girbane

DIRECTOR GENERAL, MAHRATTA CHAMBER OF COMMERCE, INDUSTRIES & AGRICULTURE (MCCIA)

Pune - India's innovation Capital

Brad Glasscock, PharmD

GROUP VICE PRESIDENT AND HEAD OF GLOBAL REGULATORY AFFAIRS, BIOMARIN

'N of Few' - Clinical Trial Design for Small Cohorts

Amanda Glassman

EXECUTIVE VICE PRESIDENT AND SENIOR FELLOW, CENTER FOR GLOBAL DEVEOPMENT

A Way Forward: Winning the War on COVID through Vaccines

John Glasspool

CEO, ANTHOS THERAPEUTICS INC

Addressing the Unmet Need in Cardiovascular Disease Development

Precision financing for Durable/curative Therapies

Cambridge MA, Massachusetts, United States

Gregory Glenn, MD

PRESIDENT, RESEARCH & DEVELOPMENT , NOVAVAX, INC

A Way Forward: Winning the War on COVID through Vaccines

Gaithersburg, Maryland, United States

Serghei Glinca

CEO, CRYSTALSFIRST GMBH

CrystalsFirst GmbH

Marburg, Germany

Mar Gonzalez-Franco

RESEARCHER, MICROSOFT RESEARCH

The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence

Redmond, Washington, United States

Greg Gorgas

PRESIDENT & CHIEF EXECUTIVE OFFICER, ARTELO BIOSCIENCES

Disruptive Thinking: What's Next for Pain

La Jolla, California, United States

Phil Gotwals

GLOBAL HEAD, NIBR BD&L, NOVARTIS

Novartis

Cambridge, Massachusetts, United States

Grace Graham

HEALTH POLICY DIRECTOR, SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS

Protecting Our Long-Term Commitment to Care in a Post-Pandemic World

Washington, United States

Stephen Graham

CEO, PICOMOLE INC.

Picomole Inc.

Moncton, New Brunswick, Canada

Barney Graham, MD, PhD

DEPUTY DIRECTOR, VRC AND CHIEF, VIRAL PATHOGENESIS LABORATORY AND TRANSLATIONAL SCIENCE CORE, NIAID, NIH

The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?

James Graham

EXECUTIVE DIRECTOR, RECCE PHARMACEUTICALS LTD

Recce Pharmaceuticals Ltd

Sydney, Australia

Charley Grant, BA, CFA

COLUMNIST, WALL STREET JOURNAL

Looking for the Next Targeted Oncology Blockbuster

New York City, New York, United States

Fabio Grassi

FOUNDER, MV BIOTHERAPEUTICS

MV BioTherapeutics SA

Bellinzona, Switzerland

Oliver Graudejus, PhD

FOUNDER, BMSEED

BMSEED

Phoenix, Arizona, United States

Larry Green

CHIEF EXECUTIVE OFFICER, ABLEXIS & ALIVAMAB DISCOVERY SERVICES

Ablexis & AlivaMab Discovery Services

San Diego, California, United States

James Greenwood

FORMER PRESIDENT AND CHIEF EXECUTIVE OFFICER, BIOTECHNOLOGY INNOVATION ORGANIZATION

Biotech’s Finest Hour

Fireside Chat with Jim Greenwood and Michelle McMurry-Heath, BIO

Washington, United States

Sunny Grewal

COO AND CO-FOUNDER, OMNY

Omny Health

San Francisco, California, United States

Bernard Grimm

DIRECTOR GENERAL, EUROPABIO

Start Me Up: How Can Europe’s Biotech Sector Combat the Coronavirus?

Brussels, Belgium

Natalie Grover

REPORTER, ENDPOINTS NEWS

Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance

London, United Kingdom

Franz Grus

CEO, MAINTECT GMBH

maintect GmbH

Mainz, Germany

Joseph Grzymski, PhD

CHIEF SCIENTIFIC OFFICER; DIRECTOR, RENOWN HEALTH; RENOWN INSTITUTE FOR HEALTH INNOVATION

Digitizing the Genome: Enabling New Models for Population-Scale Genomics

Reno, Nevada, United States

Manisha Gulati

CHIEF OPERATING OFFICER, CLARIFY HEALTH

Clarify Health

San Francisco , California, United States

Moira Gunn, BS, MS, PhD

HOST, NPR/TECH NATION; ASSOCIATE PROFESSOR, USF DIRECTOR OF BIOENTREPRENEURSHIP

Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences

Genomic medicine and bioethics – Ushering in a new era of responsible healthcare

San Francisco, California, United States

David Gustafson

EMERITUS RESEARCH PROFESSOR, UNIVERSITY OF WISCONSIN−MADISON’S CENTER FOR HEALTH ENHANCEMENT SYSTEMS STUDIES

Disruptive Thinking: New Tools To Transform Addiction Treatment

Byoung Gwag

CEO, GNT PHARMA

GNT Pharma

Yonginsi, Gyeonggido, Korea, Republic of

Christian Haas-Kwon

LIFE SCIENCE R&D ENABLEMENT LEAD, BENCHLING

Benchling

San Francisco, California, United States

Kyung soo Hahm

DIRECTOR, BIOLEADERS

BioLeaders

Yongin-si, Korea, Republic of

Todd Haim, PhD

CHIEF, OFFICE OF SMALL BUSINESS RESEARCH, NIH/NIA

Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate

Bethesda, Maryland, United States

William Hait, MD, PhD

GLOBAL HEAD, JOHNSON & JOHNSON EXTERNAL INNOVATION, JOHNSON & JOHNSON

Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe

New Brunswick, New Jersey, United States

Attila Hajdu, MBA, MS

VICE PRESIDENT, BUSINESS DEVELOPMENT, TRIPLE HAIR

Triple Hair

Vancouver, British Columbia, Canada

Jeff Haley

DEVELOPMENT, CELANESE

Celanese

Florence, Kentucky, United States

Sonia Hall, PhD

PRESIDENT & CHIEF EXECUTIVE OFFICER, BIOKANSAS

Bioscience Professional Toolkit - How to successfully transition to a post-academic career

Shawnee, Kansas, United States

Laurie Halloran

CHIEF EXECUTIVE OFFICER, HALLORAN CONSULTING GROUP

'N of Few' - Clinical Trial Design for Small Cohorts

Boston, Massachusetts, United States

Reza Halse, PhD

HEAD, PACIFIC BD&L HUB AND PRESIDENT, MRL VENTURES FUND, MERCK

Merck

South San Francisco, California, United States

Aldric Hama

DIRECTOR, HAMAMATSU PHARMA RESEARCH, INC.

Hamamatsu Pharma Research, Inc.

Hamamatsu, Japan

Margaret Hamburg, MD

FOREIGN SECRETARY, NATIONAL ACADEMIES OF SCIENCE

A Way Forward: Winning the War on COVID through Vaccines

Protecting Our Long-Term Commitment to Care in a Post-Pandemic World

Buhm Han

CTO, GENEALOGY INC.

Genealogy Inc.

Seoul, Korea, Republic of

Dong Wook Han

CTO, ORGANFACTORY

OrganFactory

Cheongju, Korea, Republic of

Grace Han McMahon, JD, MBA

HEAD OF TRANSACTIONS, BUSINESS DEVELOPMENT & LICENSING PACIFIC INNOVATION HUB, MERCK

GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes

South San Francisco, California, United States

Matt Handel

CEO, EXPRESSCELLS

ExpressCells

Philadelphia, Pennsylvania, United States

Susie Harborth

CHIEF FINANCIAL OFFICER & ADMINISTRATIVE PARTNER, MISSION BIOCAPITAL

How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond

United States

David Harel

CO-FOUNDER AND CEO, CYTOREASON

CytoReason

Tel Aviv, Israel

Robert Hariri, MD, PhD

CEO, CELULARITY

Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies

Warren, New Jersey, United States

Dan Haro

EXTERNAL ENGAGEMENT MANAGER, CORPORATE DEVELOPMENT, BIOGEN

Biogen

Cambridge, Massachusetts, United States

Meghan Harpole

NURSE, COVID-19 PATIENT, NURSE

Understanding the Voices of Patients: Unique Perspectives on Healthcare

United States

Christine Harrison

VICE PRESIDENT, CORPORATE AFFAIRS, ORCHARD THERAPEUTICS

Patient Engagement in Gene and Cell Therapy: What is Different?

District Of Columbia, United States

Beverly Harrison

HEAD, PATIENT STRATEGIES & SOLUTIONS, JANSSEN

Activating the Value of RWD/RWE in a COVID-19 World

Titusville, New Jersey, United States

Alan Hartman

PARTNER, CENTERVIEW PARTNERS

How to Get Acquired: What Companies Look for When in Acquisition Mode

Paul Hastings

PRESIDENT AND CEO, NKARTA THERAPEUTICS

Understanding the Voices of Patients: Unique Perspectives on Healthcare

Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives

South San Francisco, California, United States

Richard Hatchett

CHIEF EXECUTIVE OFFICER , CEPI

A Way Forward: Winning the War on COVID through Vaccines

London , United Kingdom

Rachel Haurwitz, PhD

PRESIDENT AND CEO, CARIBOU BIOSCIENCES

True North: Maintaining your vision and letting scientific innovation be your guide

Berkeley, California, United States

Lou Hawthorne

CEO, NANOTICS, LLC

NaNotics, LLC

Mill Valley, California, United States

Daria Hazuda

VP, INFECTIOUS DISEASES DISCOVERY & CHIEF SCIENTIFIC OFFICER, MRL CAMBRIDGE EXPLORATORY CENTER, MERCK & CO

Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance

Cambridge, Massachusetts, United States

Mary Hecht-Kissell, MBA

DIRECTOR, BUSINESS DEVELOPMENT, NORTH CAROLINA BIOTECHNOLOGY CENTER

North Carolina – a global life science leader

Research Triangle Park, North Carolina, United States

Jonathan Heeney

CEO, DIOSYNVAX LTD.

The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?

Brenda Hefti, JD, PhD

SENIOR VICE PRESIDENT, INTELLECTUAL PROPERTY AND LICENSING, EXELIXIS

GETTING TO YES: Negotiating IP Terms in Contracts

Alameda, California, United States

Karen Heichman, PhD

SENIOR PROGRAM OFFICER, DIAGNOSTIC DEVELOPMENT, INNOVATIVE TECHNOLOGY SOLUTIONS, GLOBAL HEALTH DIVISION, BILL & MELINDA GATES FOUNDATION

Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe

Mo Heidaran

VICE PRESIDENT TECHNICAL, REGULATORY AND TECHNICAL CMC CONSULTING CELL, GENE THERAPY AND TISSUE ENGINEERING, PAREXEL INTERNATIONAL

Discover/Develop: But How Will you Manufacture Your Therapeutic?

United States

Abraham Heifets, PhD

CEO, CO-FOUNDER, ATOMWISE, INC.

Atomwise, Inc.

Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development

San Francisco, California, United States

Per Hellsund, MBA

CEO, CYBREXA THERAPEUTICS

Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies

Cybrexa Therapeutics

New Haven, Connecticut, United States

Adam Hickey

DEPUTY ASSISTANT ATTORNEY GENERAL, NATIONAL SECURITY DIVISION, US DEPARTMENT OF JUSTICE

Examining Foreign-Source Threats to Biotechnology: A Conversation with the National Security Community

James J. Hickman, PhD

CHIEF SCIENTIST , HESPEROS, INC.

Disruptive Thinking: New Tools To Transform Addiction Treatment

Hesperos, Inc

Orlando, Florida, United States

Michael Higgins

MANAGING DIRECTOR, BIOPHARMACEUTICALS EQUITY RESEARCH, LADENBURG THALMANN & CO. INC.

Disruptive Thinking: What's Next for Pain

New York, New York, United States

Katherine High, MD

VISITING PROFESSOR; CO-FOUNDER AND FORMER PRESIDENT AND HEAD OF R&D, ROCKEFELLER UNIVERSITY; SPARK THERAPEUTICS

Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress

Philadelphia, Pennsylvania, United States

Quita Highsmith, MBA

CHIEF DIVERSITY OFFICER, GENENTECH

Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities

South San Francisco, California, United States

Seiji Hirasaki

CEO, ORICIRO GENOMICS

OriCiro Genomics

Tokyo, Japan

William Ho

CHIEF EXECUTIVE OFFICER, INCYSUS THERAPEUTICS, INC.

Incysus Therapeutics, Inc.

NEW YORK, New York, United States

Helen Ho, PhD

VICE PRESIDENT, HEAD OF CORPORATE DEVELOPMENT, BLUEPRINT MEDICINES

Licensing Clinical-Stage Assets to Greater China

Joshua Hoffman

CO-FOUNDER AND CEO, ZYMERGEN

The Bio Revolution: Innovations transforming economies, societies, and our lives

San Francisco, California, United States

Michele Holcomb, PhD

EXECUTIVE VICE PRESIDENT, STRATEGY AND CORPORATE DEVELOPMENT, CARDINAL HEALTH

Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases

Ohio, United States

Natalie Holles

PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES, AN ASTELLAS COMPANY

Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress

Andy Holt

VP BUSINESS DEVELOPMENT , ASKBIO

AskBio

RTP , North Carolina, United States

Axel Hoos

SENIOR VICE PRESIDENT AND THERAPEUTIC AREA HEAD ONCOLOGY, GLAXOSMITHKLINE

Future of IO Checkpoint Combinations

Collegeville, Pennsylvania, United States

W. Keith Hoots, MD

DIRECTOR, DIVISION OF BLOOD DISEASES AND RESOURCES, NATIONAL HEART, LUNG, AND BLOOD INSTITUTE- NATIONAL INSTITUTES OF HEALTH

The human biologic response to vascular injury: a complex interaction among inflammation (innate and adaptive), coagulation and acuity of the injurious stimulus

Zachary Hornby

CEO, PRESIDENT AND DIRECTOR, BOUNDLESS BIO INC.

Looking for the Next Targeted Oncology Blockbuster

La Jolla, California, United States

Ken Horne

PRESIDENT & COO, TEON THERAPEUTICS, INC.

Teon Therapeutics, Inc.

Redwood City, California, United States

Robert House

SENIOR VICE PRESIDENT, GOVERNMENT CONTRACTS, OLOGY BIOSERVICES, INC

The Need for Speed: Developing COVID-19 Vaccines and Therapeutics

Alachua, Florida, United States

Sonny Hsiao

CEO AND PRESIDENT, ACEPODIA BIOTECH, INC.

Acepodia Biotech, Inc.

Burlingame, California, United States

Dar-Jen Hsieh, PhD

CEO, ACRO BIOMEDICAL CO., LTD.

ACRO Biomedical Co., Ltd.

Kaohsiung City, Taiwan

Pearl Huang, PhD

PRESIDENT AND CEO, CYGNAL THERAPEUTICS

Getting a seat at the table: how can new small companies enter the oncology space?

Cambridge, Massachusetts, United States

Tom Hughes, PhD

CEO, NAVITOR PHARMACEUTICALS

Redefining What it Means to Get Old: New Breakthroughs in Aging Biology

Cambridge , Massachusetts, United States

Kevin Kyung-Hwa Huh

VICE CHAIRMAN, KPBMA(KOREA PHARMACEUTICAL AND BIO-PHARMA MANUFACTURERS ASSOCIATION)

KPBMA(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)

Seoul, Korea, Republic of

Greg Hunt, MP

MINISTER, DEPARTMENT OF HEALTH, AUSTRALIA

International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?

Stephen Hurst, JD

CO-FOUNDER, EXECUTIVE CHAIRMAN AND CO-CEO, MIND MEDICINE

Disruptive Thinking: New Tools To Transform Addiction Treatment

Toronto, Ontario, Canada

Patricia Hurter

CEO, LYNDRA THERAPEUTICS

Lyndra Therapeutics

Watertown , Massachusetts, United States

Mikael Hwang

BUSINESS DEVELOPMENT , GENEMEDICINE CO., LTD.

GeneMedicine Co., Ltd.

Seoul, Korea, Republic of

Albert Hwang, MD

MANAGING DIRECTOR, HEALTHCARE, INVESTMENT BANKING, MORGAN STANLEY

Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress

Robert Iannone, MD

EXECUTIVE VICE PRESIDENT, RESEARCH AND DEVELOPMENT, JAZZ PHARMACEUTICALS

Advancing Rare Disease Diagnosis and Drug Development Through Partnership

Jacqueline Iversen

FOUNDER AND HEAD OF CLINICAL DEVELOPMENT, SEN-JAM PHARMACEUTICAL

Sen-Jam Pharmaceutical

Huntington, New York, United States

Mridula Iyer

GENERAL MANAGER, PRECISION MEDICINE, QUEST DIAGNOSTICS

Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market

Ehsan Jabbarzadeh, PhD, MBA

CEO, OBSIDIO, INC.

Obsidio, Inc.

Columbia, South Carolina, United States

Mandy Jackson

MANAGING EDITOR, US COMMERCIAL NEWS, SCRIP/THE PINK SHEET

Fireside Chat with Dr. Jeff Settleman, Chief Scientific Officer for Oncology Research and Development, Pfizer

Derisking Early Research and Increasing Likelihood of Clinical Success

Derek Jantz, BA, PhD

CHIEF SCIENTIFIC OFFICER, PRECISION BIOSCIENCES

CARs in the Fast Lane? Universal Allogeneic Therapy Moving Forward

Durham, North Carolina, United States

Elizabeth Jeffords

CHIEF COMMERCIAL & STRATEGY OFFICER, ALKAHEST

Battle of the Brains: Rethinking Neurodegenerative Disease Treatment

San Carlos, California, United States

Sarah Jenna

CEO, MY INTELLIGENT MACHINES

My Intelligent Machines (MIMs)

Montreal, Quebec, Canada

Jana Jensen, PhD

CHIEF OPERATING OFFICER, DEERFIELD MANAGEMENT | DEERFIELD DISCOVERY AND DEVELOPMENT COMPANY (3DC)

Derisking Early Research and Increasing Likelihood of Clinical Success

New York, New York, United States

Samuel Ji

COO / MANAGING DIRECTOR, YBSOFT CO., LTD.

YBSOFT Co., Ltd.

Goyang-si, Korea, Republic of

Changrong Ji

ENTERPRISE ARCHITECT, CAREFIRST BLUECROSS BLUESHIELD

Can AI Prevent Epidemics?

Li Jiang

CEO, VITASCAN

VitaScan

Ithaca, New York, United States

Yefei Jin

CEO, THIRD ROOM

Third Room

Cambridge, Massachusetts, United States

Sabrina Johnson

CEO, DARé BIOSCIENCE

Redefining BioPharma in a Female-Forward World

Daré Bioscience

san diego , California, United States

Ramsey Johnson, MSM

FOUNDER AND CHAIRMAN, OUTBIO

Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives

Boston, Massachusetts, United States

Patrick Jordan

CEO, MYCOVIA PHARMACEUTICALS, INC.

Redefining BioPharma in a Female-Forward World

Durham, North Carolina, United States

Claude JORIS

SECREATARY GENERAL, BIOALPS

BioAlps: The Health Valley Ecosystem

Geneva, Switzerland

Stephen Joseph

BUSINESS DEVELOPMENT, BREX

Brex

San Francisco, California, United States

Doo Young Jung

CEO/FOUNDER, PINOTBIO, INC.

PinotBio, Inc.

Suwon, Gyeonggi-do, Korea, Republic of

Ashish Kachru, MBA, MS

CHIEF EXECUTIVE OFFICER, ALTRUISTA HEALTH

Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences

Reston, Virginia, United States

Dan Kagan, PhD

COO, SCIENTIST.COM

Scientist.com

Solana Beach, California, United States

Kenji Kakuta

PRESIDENT AND CEO, IHEART JAPAN CORPORATION

iHeart Japan Corporation

Kyoto, Japan

Rasika Kalamegham

GROUP DIRECTOR, US REGULATORY POLICY, GENENTECH

Patient-Centric 2.0: Are We Ready for Decentralized Trials?

Digital Health: Innovation Meets Regulation

Washington, United States

Kevin Kane

CEO, PHASTAR

PHASTAR

London, United Kingdom

Sukmo Kang, DVM, PhD

GENERAL MANAGER, BIOTOXTECH. CO. LTD

Biotoxtech

Cheongju-si, Korea, Republic of

Byoung Heon Kang

CEO, SMARTINBIO

SmartinBio

Osong, Korea, Republic of

Amit Kapoor

CHAIR, INSTITUTE FOR COMPETITIVENESS

The Lure of Universal Healthcare ! What India is doing in Healthcare

Gurgaon, Haryana, India

Mahesh Karande

PRESIDENT & CEO, OMEGA THERAPEUTICS

Omega Therapeutics

Cambridge, Massachusetts, United States

Tejal Karia

GLOBAL HEAD OF RISK MANAGEMENT, CATALENT PHARMA SOLUTIONS

Identify and Mitigate: “Bet Your Company” Risks

United States

Kenneth Kashkin

CHIEF OPERATING OFFICER, CHROMOCELL CORPORATION

Chromocell Corporation

North Brunswick, New Jersey, United States

David C. Kaslow, MD

VP, ESSENTIAL MEDICINES, PATH

Beyond the Needle: Novel Approaches to Vaccine Delivery

Seattle, Washington, United States

David Katz, PhD

CEO/FOUNDER, SPARROW PHARMACEUTICALS

Sparrow Pharmaceuticals

Sparrow Pharmaceuticals, Inc.

Portland, Oregon, United States

Syed Kazmi, PhD, MBA

PRESIDENT AND CEO, JUBILANT THERAPEUTICS INC

Jubilant Therapeutics Inc

Bedminster, New Jersey, United States

Michael Keane, BS

DIRECTOR OF SEARCH AND EVALUATION AT GSK CONSUMER HEALTHCARE EXTERNAL INNOVATION, GSK CONSUMER HEALTHCARE

Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences

Warren, New Jersey, United States

Ellen Kelly, PhD

DIRECTOR, BUSINESS DEVELOPMENT, CORIELL INSTITUTE FOR MEDICAL RESEARCH

Coriell Institute for Medical Research

Camden, New Jersey, United States

Larry Kelmar

VICE PRESIDENT, GOVERNMENT PROGRAMS, CEPHEID

Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics

Sunnyvale, California, United States

Ralph Kern, MD

PRESIDENT AND CHIEF MEDICAL OFFICER, BRAINSTORM CELL THERAPEUTICS

Brainstorm Cell Therapeutics

New York , New York, United States

David Kerwick

LEGAL DIRECTOR, MERCK

AI Innovations: To Patent or Not to Patent?

White Plains, New York, United States

Bill Ketelbey, MBA, MD

CEO & MANAGING DIRECTOR, ACTINOGEN MEDICAL

Actinogen Medical

Sydney, Australia

Rachna Khosla

VICE PRESIDENT, AMGEN INC.

Amgen Inc.

Thousand Oaks, California, United States

Ute Kilger

PARTNER, BOEHMERT & BOEHMERT LAW FIRM

Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future

Berlin, Germany

Nicole Kilgore

DEPUTY JOINT PRODUCT MANAGER, JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE/JOINT PRO

The Need for Speed: Developing COVID-19 Vaccines and Therapeutics

Frederick, Maryland, United States

Kyu-Tae Kim

CSO, ABCLON

AbClon

Seoul, Korea, Republic of

Hong-Yeoul Kim

CEO, HAIM BIO CO.,LTD.

Haim Bio Co.,Ltd.

Seoul, Korea, Republic of

Thomas Kim, JD, MS

PRESIDENT & CEO, EPIVARIO INC.

PTSD treatment limitations and novel pharmacotherapy approaches to transform standard of care

Lansdale, Pennsylvania, United States

Wankyu Kim

CEO, KAIPHARM CO., LTD.

KaiPharm Co., Ltd.

Seoul, Korea, Republic of

Julie Kim

PRESIDENT, PLASMA-DERIVED THERAPEUTICS BUSINESS UNIT, TAKEDA

Leveraging Innovative Technology to Treat COVID-19 Patients

Taehee Kim

PROJECT MANAGER, INCHEON FREE ECONOMIC ZONE

Incheon Free Economic Zone (IFEZ)

Andrew Kim

ASSOCIATE DIRECTOR, DSP MSAT, SAMSUNG BIOLOGICS

Samsung Biologics

Incheon, Korea, Republic of

Pk Kim

DIRECTOR, NU EYNE

Nu Eyne

Seoul-si, Korea, Republic of

J. Joseph Kim, PhD

PRESIDENT, CHIEF EXECUTIVE OFFICER, DIRECTOR, INOVIO PHARMACEUTICALS

Bioethics Through the Lens of a Pandemic

United States

Nikole Kimes

CEO AND CO-FOUNDER, SIOLTA THERAPEUTICS

Keys to the Cure: Will the Microbiome Live Up to the Hype?

United States

Nina Kjellson

MANAGING PARTNER, CANAAN PARTNERS

The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value

Menlo Park, California, United States

Thomas Kluz

SENIOR INVESTMENT MANAGER, QUALCOMM VENTURES

Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty

San Diego, California, United States

Jeff Kmetz

CHIEF BUSINESS OFFICER, ASCENTAGE PHARMA GROUP

Ascentage Pharma Group

Rockville, Maryland, United States

Rob Knight, PhD

PROFESSOR, PEDIATRICS, BIOENGINEERING, AND COMPUTER SCIENCE & ENGINEERING, UNIVERSITY OF CALIFORNIA SAN DIEGO

Next Generation Advances in Human Microbiome Research

San Diego, California, United States

Helen Knight

PROGRAMME DIRECTOR – TECHNOLOGY APPRAISAL AND HIGHLY SPECIALIZED TECHNOLOGY, NICE - NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals

Selina Koch, PhD

EXECUTIVE EDITOR, BIOCENTURY, INC.

Battle of the Brains: Rethinking Neurodegenerative Disease Treatment

The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value

United States

Wayne Koff

PRESIDENT & CEO, HUMAN VACCINES PROJECT

The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?

New York, New York, United States

Michael Kokesh, BS, JD

PRESIDENT & CEO, VICARDIA THERAPEUTICS, INC.

ViCardia Therapeutics, Inc.

San Francisco, California, United States

Daphne Koller

FOUNDER AND CEO, INSITRO, INC.

The Bio Revolution: Innovations transforming economies, societies, and our lives

South Can Francisco, California, United States

Michele Korfin, MBA, RPh

CHIEF OPERATING OFFICER, TYME TECHNOLOGIES INC

TYME Technologies Inc

New York, New York, United States

Jason Kralic, PhD

CEO AND CO-FOUNDER, TELLUS THERAPEUTICS

Tellus Therapeutics

Durham, North Carolina, United States

Carl Kraus

CEO, ARREVUS INC.

Arrevus Inc.

Raleigh, North Carolina, United States

Achim Krauss

CEO AND PRESIDENT, AXEROVISION, INC.

AxeroVision, Inc.

Carlsbad, California, United States

Pawel Krysiak

PRESIDENT & CEO, M6P THERAPEUTICS

M6P Therapeutics

San Francisco, California, United States

Hannah Kuchler

JOURNALIST, FINANCIAL TIMES

Redefining What it Means to Get Old: New Breakthroughs in Aging Biology

Carl Kukkonen

PARTNER, JONES DAY

AI Innovations: To Patent or Not to Patent?

San Diego, California, United States

Jitendra Kumar

MANAGING DIRECTOR, BANGALORE BIOINNOVATION CENTRE

Karnataka - An Emerging Bio-Innovation Hub

Seema Kumar, MS

VICE PRESIDENT OF INNOVATION, GLOBAL HEALTH AND POLICY COMMUNICATION, JOHNSON & JOHNSON INNOVATION

Science on the Front Lines & on the Front Page

The BioGENEius and GenePool Challenges

How COVID-19 Has Impacted the Global Psyche

Rebecca Kurnat

DIRECTOR, TECHNOLOGY SELECTION AND EVALUATION, JPEO-CBRND ENABLING BIOTECHNOLOGIES (JPEO-CBRND-EB)

The Need for Speed: Developing COVID-19 Vaccines and Therapeutics

Fort Detrick, Maryland, United States

Sharon Labreche

VICE PRESIDENT, GLOBAL TALENT ACQUISITION, ALNYLAM

Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives

Louise Lagerqvist

PARTNERING MANAGER, US, MEDINCELL

MedinCell

Jacou, France

Shoupeng Lai

EVP/ CO-FOUNDER, LEADS BIOLABS

LEADS BioLabs

Nanjing, China

Thomas Lake

SVP, VACCINE DEVELOPMENT ALLIANCES, VAXXAS

Beyond the Needle: Novel Approaches to Vaccine Delivery

Sydney, Australia

Janet Lambert, MBA

CEO, ARM

Patient Engagement in Gene and Cell Therapy: What is Different?

Washington DC, District Of Columbia, United States

Jordan Lancaster, PhD

CEO, AVERY THERAPEUTICS, INC

Avery Therapeutics, Inc

Tucson, Arizona, United States

Gerardo Lancia, MBA

HEAD OF TECH TRASFER, CLUSTER & SPECIAL PROJECTS - LAZIO INNOVA SPA, LAZIO INNOVA SPA

Invest in Lazio

Rome, Italy

Paul Langley

HEALTH ECONOMIST, MAIMON RESEARCH LLC

Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage

Tucson, Arizona, United States

James Lanthier

CEO, MINDSET PHARMA

Mindset Pharma

Toronto, Ontario, Canada

Donna LaVoie

PRESIDENT & CEO, LAVOIEHEALTHSCIENCE

The Power of Content in Your Virtual Presentation – How to Create Your Company Presentation in Just 15 Slides

Boston, Massachusetts, United States

Matthew Lawrence, MD, PhD

CHIEF EXECUTIVE OFFICER & CHIEF SCIENTIFIC OFFICER, VIRSCIO

Battle of the Brains: Rethinking Neurodegenerative Disease Treatment

New Haven, Connecticut, United States

David Leach

CEO, LIGNAMED, LLC

LignaMed, LLC

Philadelphia, Pennsylvania, United States

Thomas Leary

PROTEIN PRODUCT SPECIALIST, DNASTAR, INC.

DNASTAR Inc.

Madison, Wisconsin, United States

Seth Lederman

CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS HOLDING CORP/.

Tonix Pharmaceutical Holding Corp.

New York, New York, United States

Johnsee Lee, MBA, PhD

FOUNDER AND CEO, PERSONAL GENOMICS, INC.

Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe

Personal Genomics, Inc.

Zhubei, Hsinchu, Taiwan

Merissa Lee, BSc

BD SPECIALIST, SYNCORE BIOTECHNOLOGY

SynCore Biotechnology

Taipei, Taiwan

Bora Lee

IP & BD MANAGER, BIONOXX

Bionoxx Inc.

Yangsan-si, Korea, Republic of

Victor Lee

CEO, VICTOGEN

VictoGen

Thousand Oaks, California, United States

Kyuho Lee

CEO, ATOMICS AI

Atomics AI

Cheongju, Korea, Republic of

Yuta Lee, MBA

CEO, ACCELERATED BIOSCIENCES

Accelerated Biosciences

Carlsbad, California, United States

Kevin Lee, PhD

CEO, BICYCLE THERAPEUTICS

Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies

Lexington, Massachusetts, United States

Peter Lee

CORPORATE VICE PRESIDENT, AI AND RESEARCH, MICROSOFT

The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable

Seattle, Washington, United States

Arlinda Lee, PhD

ANALYST , CANACCORD GENUITY

Bispecific Antibodies Catching Fire

New York , New York, United States

Christian Leisner

CEO, CDR-LIFE

CDR-Life

Schlieren - Zurich, Switzerland

Anna Lembke, MD

ASSOCIATE PROFESSOR OF PSYCHIATRY AND BEHAVIORAL SCIENCES, STANFORD UNIVERSITY MEDICAL CENTER

Disruptive Thinking: New Tools To Transform Addiction Treatment

Christine Lemke, PhD

EVIDATION HEALTH, CO-FOUNDER AND PRESIDENT, EVIDATION HEALTH

The Emerging Role of Digital Biomarkers in Cognitive Impairment

San Mateo, California, United States

Stephan Lensky

COO/CBO, EPIMAB BIOTHERAPEUTICS

EpimAb Biotherapeutics

NEW BRAINTREE, Massachusetts, United States

Stephanie Leouzon

PARTNER AND HEAD OF TORREYA EUROPE, TORREYA

Is It Time to Reconsider M&A’s Role in Portfolio Building?

London, United Kingdom

Nick Leschly

PRESIDENT & CEO, BLUEBIRD BIO

Next Generation Orphan Drug Incentives

Cambridge, Massachusetts, United States

Rachael Lester

VICE PRESIDENT OF CORPORATE DEVELOPMENT, HARPOON THERAPEUTICS

Restarting the Bioeconomy: What IPO and Alliance Data tell us

United States

Kirsten Leute

PARTNER, UNIVERSITY RELATIONS, OSAGE UNIVERSITY PARTNERS

Derisking Early Research and Increasing Likelihood of Clinical Success

Bala Cynwyd, Pennsylvania, United States

Matthieu Leuwers

CHIEF BD OFFICER, PROVEPHARM LIFE SOLUTIONS

Provepharm Life Solutions

Marseille, France

Jeremy Levin, MB BChir, D. Phil

CHAIRMAN OF THE BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICER, OVID THERAPEUTICS INC.

Biotech’s Finest Hour

Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World

Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe

New York, New York, United States

Cynthia Li

DIRECTOR, BUSINESS DEVELOPMENT, EXELIXIS

GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes

Alameda, California, United States

Mike Liccardo

VP CORP. DEV. & CFO, SHAREVAULT

ShareVault

Los Gatos, CA, California, United States

Jay Lichter, PhD

MANAGING DIRECTOR, AVALON VENTURES; PRESIDENT & CEO, COI PHARMACEUTICALS, AVALON VENTURES

The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value

La Jolla, California, United States

Emmanuel Ligner

PRESIDENT & CEO, CYTIVA

Cytiva

Chern-Hooi Lim, PhD

CEO, NEW IRIDIUM

New Iridium

Boulder, Colorado, United States

Erick Lin

MEDICAL DIRECTOR, MEDICAL AFFAIRS LEAD, BLUE CROSS BLUE SHIELD ASSOCIATION

Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies

Temple City , California, United States

George Lin

EVP & CFO, HUA MEDICINE

Hua Medicine

Hong Kong, Hong Kong

Klaus Lindpaintner

CSO/CMO, INTERVENN

InterVenn

South San Francisco, California, United States

Evan Lippman

HEAD OF CORPORATE DEVELOPMENT AND BD FINANCE, GLOBAL BUSINESS DEVELOPMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED

Is It Time to Reconsider M&A’s Role in Portfolio Building?

Cambridge, Massachusetts, United States

Donald Lo, PhD

DIRECTOR, DIVISION OF PRECLINICAL INNOVATION, THERAPEUTIC DEVELOPMENT BRANCH, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NATIONAL INSTITUTES OF HEALTH

Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective

United States

Christopher Locher

CEO, VERSATOPE THERAPEUTICS, INCORPORATED

Versatope Therapeutics, Inc.

Lowell, Massachusetts, United States

Rob Long

EXECUTIVE DIRECTOR, UPLIFTING ATHLETES

Uplifting Athletes

Chester Springs, Pennsylvania, United States

Katrina Loomis

EXECUTIVE DIRECTOR, HEAD OF EMERGING PORTFOLIO, EMERGING SCIENCE & INNOVATION, PFIZER

Digitizing the Genome: Enabling New Models for Population-Scale Genomics

Ted Love, MD

PRESIDENT & CHIEF EXECUTIVE OFFICER, GLOBAL BLOOD THERAPEUTICS

Advancing Rare Disease Diagnosis and Drug Development Through Partnership

Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World

Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities

South San Francisco, California, United States

Jeffrey Lu

CEO AND CO-FOUNDER, ENGINE BIOSCIENCES

Engine Biosciences

San Carlos, California, United States

James Lu, MD, PhD

CO-FOUNDER & CHIEF SCIENTIFIC OFFICER, HELIX

Helix

Digitizing the Genome: Enabling New Models for Population-Scale Genomics

San Mateo, California, United States

Heinz Lubenau

CHIEF EXECUTIVE OFFICER, VAXIMM AG

Vaximm AG

Basel, Switzerland

Shun Luo

CEO, CHAIRMAN, JIANSHUN BIOSCIENCES

Thousand Oaks Biopharmaceuticals

Shanghai, China

Tia Lyles-Williams, MSc

FOUNDER & CEO, LUCASPYE BIO

LucasPye BIO, LLC

Elizabeth, New Jersey, United States

Steven Lynum

EXECUTIVE DIRECTOR (BASED IN USA), PHC CORPORATION

PHC Corporation

Livingston, New Jersey, United States

Sandy Macrae, PhD

CEO, SANGAMO THERAPEUTICS

Genomic medicine and bioethics – Ushering in a new era of responsible healthcare

San Francisco, California, United States

Marinna Madrid

CO-FOUNDER, CELLINO

Cellino

Cambridge, Massachusetts, United States

Carmen Maher

SENIOR DIRECTOR MEDICAL REGULATORY/SENIOR REGULATORY ADVISOR, JPEO CBRND AND DEFENSE THREAT REDUCTION AGENCY / JOINT SCIENCE AND TECHNOLOGY OFFICE (DTRA / JSTO)

Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics

Fort Detrick, Maryland, United States